Xu Zhao

1.5k total citations · 1 hit paper
41 papers, 904 citations indexed

About

Xu Zhao is a scholar working on Pharmacology, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Xu Zhao has authored 41 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Epidemiology and 6 papers in Psychiatry and Mental health. Recurrent topics in Xu Zhao's work include Drug-Induced Hepatotoxicity and Protection (7 papers), Epilepsy research and treatment (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xu Zhao is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (7 papers), Epilepsy research and treatment (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xu Zhao collaborates with scholars based in China, United States and Norway. Xu Zhao's co-authors include Zhiqiang Zhou, Hao Yu, Xu Sun, Wei Deng Solvang, Huicong Kang, Shiyong Li, Wenzhen Zhu, Ying Xiong, Fan Yang and Xiaodan Chen and has published in prestigious journals such as Scientific Reports, The FASEB Journal and International Journal of Cancer.

In The Last Decade

Xu Zhao

35 papers receiving 880 citations

Hit Papers

Reverse Logistics Network Design for Effective Management... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China)
    2020 239 citations Hao Yu, Xu Sun et al. International Journal of Environmental Research and Public Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Zhao China 13 276 199 154 111 93 41 904
Lin Shen China 21 217 0.8× 45 0.2× 456 3.0× 258 2.3× 48 0.5× 100 1.4k
Yimin Zhang China 11 156 0.6× 6 0.0× 214 1.4× 45 0.4× 43 0.5× 23 637
Zhirong Liu China 16 75 0.3× 66 0.3× 160 1.0× 153 1.4× 7 0.1× 66 747
Hakan Yavuzer Türkiye 16 97 0.4× 28 0.1× 119 0.8× 202 1.8× 2 0.0× 76 888
Md Rezaul Karim Bangladesh 15 43 0.2× 34 0.2× 46 0.3× 134 1.2× 24 0.3× 45 578
Panagiotis Giannos United Kingdom 18 48 0.2× 106 0.5× 74 0.5× 150 1.4× 44 970
Ryszard Sitarz Poland 12 145 0.5× 23 0.1× 174 1.1× 163 1.5× 4 0.0× 19 788
Peter Lacy United Kingdom 18 35 0.1× 70 0.4× 14 0.1× 85 0.8× 8 0.1× 41 2.9k
Irene Looi Malaysia 17 118 0.4× 44 0.2× 52 0.3× 137 1.2× 1 0.0× 69 972

Countries citing papers authored by Xu Zhao

Since Specialization
Citations

This map shows the geographic impact of Xu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Zhao more than expected).

Fields of papers citing papers by Xu Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Zhao. The network helps show where Xu Zhao may publish in the future.

Co-authorship network of co-authors of Xu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Zhao. A scholar is included among the top collaborators of Xu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Zhao. Xu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Qinghua, et al.. (2025). Design, Synthesis, Evaluation, and Molecular Dynamics Simulation of SARS-CoV-2 Mpro Inhibitors. ACS Medicinal Chemistry Letters. 16(4). 668–674. 1 indexed citations
3.
4.
5.
Zhao, Xu, Yuanhao Li, Shanshan Huang, et al.. (2023). The asymmetry of glymphatic system dysfunction in patients with temporal lobe epilepsy: A DTI-ALPS study. Journal of Neuroradiology. 50(6). 562–567. 31 indexed citations
6.
Wu, Chengzhao, Ming Niu, Zhaofang Bai, et al.. (2023). Aripiprazole-induced liver injury: a spontaneous reporting database study. Frontiers in Pharmacology. 14. 1226386–1226386. 1 indexed citations
7.
Xiao, Xiaohe, Xu Zhao, Zhaofang Bai, Jiabo Wang, & Haibo Song. (2023). [New outlook on safety of traditional Chinese medicine: concept and practice].. PubMed. 48(10). 2557–2564. 8 indexed citations
8.
Zhao, Xu, Huicong Kang, Zhiqiang Zhou, et al.. (2022). Interhemispheric functional connectivity asymmetry is distinctly affected in left and right mesial temporal lobe epilepsy. Brain and Behavior. 12(3). e2484–e2484. 8 indexed citations
9.
Chen, Shuaishuai, Xu Zhao, Ying Huang, et al.. (2022). Metabolomics coupled with network pharmacology study on the protective effect of Keguan-1 granules in LPS-induced acute lung injury. Pharmaceutical Biology. 60(1). 525–534. 6 indexed citations
10.
Zhang, Cui, et al.. (2022). New insight into methamphetamine-associated heart failure revealed by transcriptomic analyses: Circadian rhythm disorder. Toxicology and Applied Pharmacology. 451. 116172–116172. 3 indexed citations
11.
Niu, Ming, Xu Zhao, Yuming Guo, et al.. (2022). Metabolomic profiling for drug-induced liver injury with autoantibodies. International Immunopharmacology. 111. 109084–109084.
12.
Zhao, Xu, Xuebing Chen, Zhengxiang Gao, et al.. (2021). Methamphetamine exposure induces neuronal programmed necrosis by activating the receptor‐interacting protein kinase 3 ‐related signalling pathway. The FASEB Journal. 35(5). e21561–e21561. 21 indexed citations
13.
Gao, Zhengxiang, et al.. (2021). Pathological methamphetamine exposure triggers the accumulation of neuropathic protein amyloid-β by inhibiting UCHL1. NeuroToxicology. 86. 19–25. 6 indexed citations
14.
Zhang, Dongni, et al.. (2021). Renal tissue desaturation and acute kidney injury in infant cardiac surgery: a prospective propensity score-matched cohort study. British Journal of Anaesthesia. 127(4). 620–628. 10 indexed citations
15.
Chen, Lisheng, Xu Zhao, Shizhang Wei, et al.. (2021). Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology. Frontiers in Pharmacology. 12. 737630–737630. 19 indexed citations
16.
Li, Youzhi, et al.. (2021). A Novel Loss-of-Function Mutation in the NPRL3 Gene Identified in Chinese Familial Focal Epilepsy with Variable Foci. Frontiers in Genetics. 12. 766354–766354. 7 indexed citations
17.
18.
Yu, Hao, Xu Sun, Wei Deng Solvang, & Xu Zhao. (2020). Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China). International Journal of Environmental Research and Public Health. 17(5). 1770–1770. 239 indexed citations breakdown →
19.
Zhou, Zhiqiang, Huicong Kang, Shiyong Li, & Xu Zhao. (2020). Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. Journal of Neurology. 267(8). 2179–2184. 268 indexed citations
20.
Chen, Xuebing, et al.. (2019). Role of C/EBP-β in Methamphetamine-Mediated Microglial Apoptosis. Frontiers in Cellular Neuroscience. 13. 366–366. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Shen Breakdown of academic impact, for papers by Yimin Zhang Breakdown of academic impact, for papers by Zhirong Liu Breakdown of academic impact, for papers by Hakan Yavuzer Breakdown of academic impact, for papers by Md Rezaul Karim Breakdown of academic impact, for papers by Panagiotis Giannos Breakdown of academic impact, for papers by Ryszard Sitarz Breakdown of academic impact, for papers by Peter Lacy Breakdown of academic impact, for papers by Irene Looi
Rankless by CCL
2026